Clinical Trials Browser

NIH × Unspecified Adult Solid Tumor, Protocol Specific × trioctyl phosphine oxide × Clear all

NCT00068484 2013-02-01

A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific